As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 9/12/22  Annovis Bio, Inc.                 8-K:5,9      9/9/22   11:285K                                   Toppan Merrill/FA        
  8/8/22  Annovis Bio, Inc.                 10-Q        6/30/22   52:3.2M                                   Toppan Merrill Bridge/FA 
  8/8/22  Annovis Bio, Inc.                 8-K:2,9      8/8/22   11:223K                                   Toppan Merrill/FA        
  6/3/22  Annovis Bio, Inc.                 8-K:5        6/2/22   10:196K                                   Toppan Merrill/FA        
  5/4/22  Annovis Bio, Inc.                 10-Q        3/31/22   52:2.9M                                   Toppan Merrill Bridge/FA 
  5/4/22  Annovis Bio, Inc.                 8-K:2,9      5/4/22   11:215K                                   Toppan Merrill/FA        
  3/2/22  Annovis Bio, Inc.                 10-K       12/31/21   66:5.9M                                   Toppan Merrill Bridge/FA 
11/26/21  Annovis Bio, Inc.                 25         11/26/21    1:11K                                    Toppan Merrill/FA        
11/15/21  Annovis Bio, Inc.                 8-K:3,7,9  11/15/21   11:207K                                   Toppan Merrill/FA        
11/12/21  Annovis Bio, Inc.                 8-K:7,9    11/12/21   11:338K                                   Toppan Merrill/FA        
 11/3/21  Annovis Bio, Inc.                 10-Q        9/30/21   57:3.8M                                   Toppan Merrill Bridge/FA 
 10/5/21  Annovis Bio, Inc.                 8-K:7,9     10/5/21   12:3.2M                                   Toppan Merrill/FA        
 8/11/21  Annovis Bio, Inc.                 8-K:7,9     8/11/21   11:241K                                   Toppan Merrill/FA        
 7/29/21‡ Annovis Bio, Inc.                 8-K:7,9     7/28/21   11:4.4M                                   Toppan Merrill/FA        
 7/28/21  Annovis Bio, Inc.                 10-Q        6/30/21   58:3.5M                                   Toppan Merrill Bridge/FA 
  6/3/21  Annovis Bio, Inc.                 8-K:5        6/1/21    1:32K                                    Toppan Merrill/FA        
 5/24/21  Annovis Bio, Inc.                 8-K:1,8,9   5/21/21    5:363K                                   Toppan Merrill/FA        
  5/6/21  Annovis Bio, Inc.                 10-Q        3/31/21   58:3M                                     Toppan Merrill Bridge/FA 
 4/15/21  Annovis Bio, Inc.                 8-K:5,9      4/9/21    2:33K                                    Toppan Merrill/FA        
 3/23/21  Annovis Bio, Inc.                 8-K:7,9     3/23/21    2:7.5M                                   Toppan Merrill/FA        

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-K	Annual Report — Form 10-K.
	10-Q	Quarterly Report — Form 10-Q.
	25	Notice by an Issuer of the Removal from Listing and Registration on a Securities Exchange of Matured, Redeemed or Retired Securities — Form 25.